A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

Volumn 1, Issue 2, 2015, Pages 136-143

  Thomson, Kelsey L ^a   Yeo, Jing Ming ^b   Waddell, Briony ^c   Cameron, James R ^c,d   Pal, Suvankar ^c,d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Alzheimer's disease; Dementia; Mild cognitive impairment; OCT; Optical coherence tomography; Retinal imaging

Indexed keywords

EID: 84938693850     PISSN: None     EISSN: 23528729     Source Type: Journal    
DOI: 10.1016/j.dadm.2015.03.001     Document Type: Review

References (34)

1. London A., Benhar I., Schwartz M. The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol 2013, 9:44-53.
2. Trick G.L., Trick L.R., Morris P., Wolf M. Visual field loss in senile dementia of the Alzheimer's type. Neurology 1995, 45:68-74.
3. Galetta K.M., Calabresi P.A., Frohman E.M., Balcer L.J. Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration. Neurotherapeutics 2011, 8:117-132.
4. Jindahra P., Hedges T.R., Mendoza-Santiesteban C.E., Plant G.T. Optical coherence tomography of the retina: applications in neurology. Curr Opin Neurol 2010, 23:16-23.
5. Günes A., Demirci S., Tok L., Tok Ö., Demerci S. Evaluation of retinal nerve fiber layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography. Turk J Med Sci 2014, 44. 10.3906/sag-1405-114.
6. Polo V., Garcia-Martin E., Bambo M.P., Pinilla J., Larrosa J.M., Satue M., et al. Reliability and validity of Cirrus and Spectralis optical coherence tomography for detecting retinal atrophy in Alzheimer's disease. Eye 2014, 28:680-690.
7. Kirbas S., Turkyilmaz K., Anlar O., Tufekci A., Durmus M. Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol 2013, 33:58-61.
8. Kang B.H., Kim J.I. Decreased retinal thickness in patients with Alzheimer's disease. J Korean Neurol Assoc 2013, 31:173-177.
9. Ascaso F.J., Cruz N., Modrego P.J., Lopez-Anton R., Santabarbara J., Pascual L.F., et al. Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study. JNeurol 2014, 261:1522-1530.
10. Kesler A., Vakhapova V., Korczyn A.D., Naftaliev E., Neudorfer M. Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg 2011, 113:523-536.
11. Paquet C., Boissonnot M., Roger F., Dighiero P., Gil R., Hugon J. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2007, 420:97-99.
12. Iseri P.K., Altinas O., Tokay T., Yüksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuro-Ophthalmol 2006, 26:18-24.
13. Parisi V., Restuccia R., Fattapposta F., Mina C., Bucci M.G., Pierelli F. Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol 2001, 112:1860-1867.
14. Berisha F., Feke G.T., Trempe C.L., McMeel W., Schepens C.L. Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci 2007, 48:2285-2289.
15. Garcia-Martin E.S., Rojas B., Ramirez A., de Hoz R., Salazar R.J., Yubero R., et al. Macular thickness as a potential biomarker of mild Alzheimer's disease. Ophthalmology 2014, 121:1149-1153.
16. McKhann G.M., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimers disease: a report of the NINCDS-ADRDA workgroup. Neurology 1984, 34:934-942.
17. Whiting P., Rutjes A.W., Reitsma J.B., Bossuyt P.M., Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25.
18. RevMan: 5.3: Review Manager (RevMan) [Computer program]. Version 5.3 2014, The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen.
19. Chi Y., Wang Y.H., Yang L. The investigation of retinal nerve fibre loss in Alzheimer's disease. Zhonghua Yan Ke Za Zhi 2010, 46:134-139.
20. Gharbiya M., Trebbastoni A., Parisi F., Manganiello S., Cruciani F., D'Antonio F., et al. Choroidal thinning as a new finding in Alzheimer's disease: evidence from enhanced depth imaging spectral domain optical coherence tomography. J Alzheimers Dis 2014, 40:907-917.
21. Kromer R., Serbecic N., Hausner L., Froelich L., Aboul-Enein F., Beutelspacher S.C. Detection of retinal nerve fiber layer defects in Alzheimer's disease using SD-OCT. Front Psychiatry 2014, 5:22.
22. Larrosa J.M., Garcia-Martin E., Bambo M.P., Pinilla J., Polo V., Otin S., et al. Potential new diagnostic tool for Alzheimer's disease using a linear discriminant function for Fourier domain optical coherence tomography. Invest Ophthalmol Vis Sci 2014, 55:3043-3051.
23. Moreno-Ramos T., Benito-Leon J., Villarejo A., Bermejo-Pareja F. Retinal nerve fiber layer thinning in dementia associated with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease. JAlzheimers Dis 2013, 34:659-664.
24. Zhu L.P., Ren X.L., Wang Y.X., Xu L., Zhang X.J. Retinal nerve fiber layer thickness in the patients with mild cognitive impairment or Alzheimer's disease. Ophthalmol CHN 2014, 23:231-234.
25. Shen Y., Shi Z., Jia R., Zhu Y., Cheng Y., Feng W., et al. The attenuation of retinal fiber layer thickness and cognitive deterioration. Front Cell Neurosci 2013, 7:142.
26. Marziani E., Pomati S., Ramolfo P., Cigada M., Giani A., Mariani C., et al. Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 2013, 54:5953-5958.
27. Gramer E., Dirmeyer M. Optical coherence tomography (OCT) to measure nerve fiber layer thickness in normal eyes. Invest Ophthalmol Vis Sci 1998, 39:S933. (ARVO abstract no. 4296).
28. He X.F., Liu Y.T., Peng C., Zhang F., Zhuang S., Zjang J.S. Optical coherence tomography assessed retinal nerve fiber layer thickness in patients with Alzheimer's disease: a meta-analysis. Int J Ophthalmol 2012, 5:401-405.
29. Beach T.G., Monsell S.E., Philips L.E., Kukull W. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centres 2005-2010. J Neuropathol Exp Neurol 2012, 71:266-273.
30. MacGillivray T.J., Trucco E., Cameron J.R., Dhillon B., Houston J.G., van Beek E.J. Retinal imaging as a source of biomarkers for diagnosis, characterization and prognosis of chronic illness or long-term conditions. Br J Radiol 2014, 87:20130832.
31. Patton N., Aslam T., MacGillivray T.J., Pattie A., Deary I.J., Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat 2005, 206:319-348.
32. de Jong F.J., Schrijvers E.M., Ikram M.K., Koudstaal P.J., de Jong P.T., Hofman A., et al. Retinal vascular caliber and risk of dementia: the Rotterdam study. Neurology 2011, 76:816-821.
33. Frost S., Kanagasingam Y., Sohrabi H., Vignarajan J., Bourgeat P., Salvado O., et al. Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease. Transl Psychiatry 2013, 3:e233. AIBL Research Group.
34. Cheung C.Y., Ong Y.T., Ikram M.K., Ong S.Y., Li X., Hilal S., et al. Microvascular network alterations in the retina of patients with Alzheimer's disease. Alzheimers Dement 2014, 10:135-142.